| |
KOMISJA NADZORU FINANSOWEGO |
|
| |
|
|
Raport bieżący nr |
14 |
/ |
2020 |
|
|
|
| |
Data sporządzenia: |
2020-04-21 |
|
|
|
|
|
|
|
|
|
| |
Skrócona nazwa emitenta |
|
|
|
|
|
|
|
|
|
| |
MILESTONE MEDICAL |
|
| |
Temat |
|
|
|
|
|
|
|
|
|
|
| |
Validation and Integration of CathCheck™ Feature into the CompuFlo® Epidural System
|
|
| |
Podstawa prawna |
|
|
|
|
|
|
|
|
| |
Art. 17 ust. 1 MAR - informacje poufne.
|
|
| |
Treść raportu: |
|
|
|
|
|
|
|
|
|
| |
The Board of Directors of Milestone Medical Inc. _WAR: MMD, “the Company", “the Issuer"_
today announced that it has validated and integrated the new CathCheck™ feature into
the CompuFlo® Epidural System. Using CathCheck™, physicians and nurses can monitor
the placement of a catheter to determine the presence or absence of a pulsatile waveform
_heartbeat_ providing new information that can be used to determine if the catheter
is in place or has become dislodged from the epidural space. This can be performed
within seconds by measuring the pulsatile waveform within the epidural space. This
capability saves time and money and provides better patient care.
The Board of Directors of the Issuer commented that “CathCheck™ marks a technological
leap forward in both the capabilities and intellectual property surrounding the CompuFlo®
Epidural System—adding another 20 years to our patent protection. This capability
makes CompuFlo® the first and only known instrument that can confirm the placement
of a catheter within seconds, versus 20–40 minutes using conventional methods. Traditionally,
the only way to verify placement was through a bolus injection of medication, and
waiting an extended period to subjectively measure patient response. With this new
feature, physicians and nurses can verify in near real-time that the catheter is placed
correctly, and can re-check the catheter every time the patient is moved and throughout
the day to ensure that the catheter has not been dislodged.
The Board of Directors of the Issuer believes that the confidence gained with CathCheck™
and its ability to check catheter placement should cross over to the epidural procedure
itself, where physicians and anesthesiologists can use the CompuFlo to further verify
needle placement in the epidural space and provide supporting documentation throughout
and after the procedure.
From the standpoint of the hospital, the Issuer discovered during clinical evaluations
that checking catheters throughout the day not only takes a lot of time but is costly
to the institution. Epidural catheters dislodge an estimated 3-4 times a day. The
average hospital has anywhere from 6-10 patients per day and larger hospitals have
as many as 20-30 patients each day, or more, with catheters post birth. Given these
numbers, The Board of Directors of the Issuer believes the CathCheck™ feature will
help to significantly reduce time and cost for the institution. More importantly,
The Board of Directors of the Issuer believes CathCheck™ will help improve the overall
patient experience, by ensuring the patient gets the necessary medication without
delay.
Utilizing a high-resolution in-line pressure sensor in combination with the unique
data processing within the CompuFlo System, CathCheck™ is capable of detecting both
the in-situ pressure as well as the presence of a pulsatile pressure waveform. The
pulsatile waveform is representative of the detection of pressures that are produced
by the cardio-vascular system either directly or indirectly. This in turn can be used
to aid in the identification of a needle or a catheter within an anatomic structure
such as the epidural space. This same system can be used to aid in the determination
of the patency of a catheter and to assist in determining if a catheter has been displaced
during a procedure.
|
|
|
RB_ASO: Validation and Integration of CathCheck™ Feature into the CompuFlo® Epidural System
